1216 related articles for article (PubMed ID: 10980465)
1. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
3. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
[TBL] [Abstract][Full Text] [Related]
4. Treatment of alopecia areata with squaric acid dibutylester.
Caserio RJ
Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
6. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
[TBL] [Abstract][Full Text] [Related]
7. Treatment of alopecia areata with squaric acid dibutylester.
Hill ND; Bunata K; Hebert AA
Clin Dermatol; 2015; 33(3):300-4. PubMed ID: 25889130
[TBL] [Abstract][Full Text] [Related]
8. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
Miranda A; Mato F; Quiñones PA
Med Cutan Ibero Lat Am; 1984; 12(3):273-8. PubMed ID: 6384701
[TBL] [Abstract][Full Text] [Related]
9. Morphological analysis of hair follicles in alopecia areata.
Tobin DJ
Microsc Res Tech; 1997 Aug; 38(4):443-51. PubMed ID: 9297694
[TBL] [Abstract][Full Text] [Related]
10. Alopecia areata versus juvenile alopecia in C3H/HeJ mice: tools to dissect the role of inflammation in focal alopecia.
McElwee KJ; Boggess D; King LE; Sundberg JP
Exp Dermatol; 1999 Aug; 8(4):354-5. PubMed ID: 10439272
[No Abstract] [Full Text] [Related]
11. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin.
Tang L; Cao L; Sundberg JP; Lui H; Shapiro J
Exp Dermatol; 2004 Jan; 13(1):5-10. PubMed ID: 15009110
[TBL] [Abstract][Full Text] [Related]
12. [DNCB therapy of alopecia areata].
Happle R
Z Hautkr; 1979 May; 54(10):426-9. PubMed ID: 314203
[TBL] [Abstract][Full Text] [Related]
13. Topical immunotherapy of alopecia areata. A follow-up study.
Valsecchi R; Cainelli T; Foiadelli L; Rossi A
Acta Derm Venereol; 1986; 66(3):269-72. PubMed ID: 2426909
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
[TBL] [Abstract][Full Text] [Related]
15. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
[TBL] [Abstract][Full Text] [Related]
16. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
[TBL] [Abstract][Full Text] [Related]
17. Transient leucoderma appearing in an untreated area following contact immunotherapy for alopecia areata.
Nasca MR; Micali G; Pulvirenti N; Licastro Cicero R
Eur J Dermatol; 1998 Mar; 8(2):125-6. PubMed ID: 9649675
[TBL] [Abstract][Full Text] [Related]
18. Diphencyprone in the treatment of alopecia areata.
Happle R; Hausen BM; Wiesner-Menzel L
Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
[TBL] [Abstract][Full Text] [Related]
19. Alopecia areata in aging C3H/HeJ mice.
Sundberg JP; Cordy WR; King LE
J Invest Dermatol; 1994 Jun; 102(6):847-56. PubMed ID: 8006447
[TBL] [Abstract][Full Text] [Related]
20. Alopecia areata in Eringer cows.
Timm K; Rüfenacht S; von Tscharner C; Bornand VF; Doherr MG; Oevermann A; Flury C; Rieder S; Hirsbrunner G; Drögemüller C; Roosje PJ
Vet Dermatol; 2010 Dec; 21(6):545-53. PubMed ID: 20626715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
